Live feed01:00:00·9mPRReleasevia QuantisnowPharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic useByQuantisnow·Wall Street's wire, on your screen.PHAR· Pharming Group N.V. ADS each representing 10Health Care